SeaStar Medical (NASDAQ:ICUCW – Get Free Report) is expected to be announcing its results after the market closes on Wednesday, August 12th. Analysts expect SeaStar Medical to post earnings of ($0.97) per share and revenue of $0.4860 million for the quarter.

SeaStar Medical stock opened at $0.02 on Monday. The firm has a 50-day moving average of $0.02 and a 200-day moving average of $0.02. SeaStar Medical has a 1-year low of $0.01 and a 1-year high of $0.07.

(Get Free Report)

SeaStar Medical, Inc is a medical device company developing dynamic instrument systems that replicate human wrist motion to enhance dexterity in minimally invasive surgery. The company’s technology provides surgeons with “wristed” articulation capabilities via a mechanically actuated linkage, offering a low-profile and cost-effective alternative to traditional robotic platforms.

SeaStar’s signature instrument platform is designed to integrate with existing laparoscopic trocars, enabling a seamless transition for operating rooms accustomed to conventional laparoscopic equipment.

• Five stocks we like better than SeaStar Medical
• Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
• Can DICK’S Turn Foot Locker Into a Winner?
• Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue
• Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War

Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.